Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period

Bibliographic Details
Main Author: Sousa, Patrícia
Publication Date: 2025
Other Authors: Delgado, Lucinda, Correia-de-Oliveira, Susana, Pereira, Cecília, Dias, Ângela, Tavares, Ana Cláudia
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630
Summary: Introduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower.
id RCAP_b8a9c30132676d08855aa9056579adb5
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/21630
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year PeriodInfeções do Trato Urinário em Pediatria: Evolução da Etiologia e Padrões de Resistências Locais ao Longo de Três AnosChildDrug Resistance, BacterialUrinary Tract Infections/drug therapyUrinary Tract Infections/etiologyUrinary Tract Infections/microbiologyCriançaInfeções do Trato Urinário/etiologiaInfeções do Trato Urinário/microbiologiaInfeções do Trato Urinário/tratamento farmacológicoResistência Bacteriana a MedicamentosIntroduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower.Introdução: As infeções do trato urinário são comuns em idade pediátrica. Conhecer a etiologia e os padrões de resistência locais é fundamental na determinação do tratamento empírico. Propusemo-nos a rever os patógenos implicados nas infeções do trato urinário, os padrões de resistência locais e o impacto do ajuste da antibioterapia de primeira-linha de acordo com as mesmas. Métodos: Conduzimos um estudo transversal que incluiu os doentes pediátricos que realizaram urocultura num hospital do Norte de Portugal durante dois períodos: 2019 (grupo 1) e 2022 (grupo 2). Entre estes dois períodos, foi instituído um protocolo interno de atuação clínica que recomendava a utilização de cefuroxima como antibioterapia empírica de primeira linha, de acordo com a epidemiologia local. Os grupos foram comparados quanto aos uropatógenos identificados, respetivos padrões de resistência a antimicrobianos e antibioterapia empírica instituída.Resultados: Foram identificados 402 casos de infeções do trato urinário no grupo 1 e 398 no grupo 2. A Escherichia coli (E. coli) foi o uropatógeno mais comum (79,4% - 83,3%), seguido do Proteus mirabilis e da Klebsiella spp. No grupo 1, o antimicrobiano empírico mais frequentemente selecionado foi a amoxicillina-clavulanato (A-C), enquanto no grupo 2 foi a cefuroxima (p < 0.001). A resistência mais frequentemente identificada foi à ampicilina (39.3% - 39.7%). A resistência a A-C não mostrou alterações estatisticamente significativas entre grupos (33,1% vs 27,4%, p = 0,079), tal como a resistência à cefuroxima (4,7% vs 3,3%, p = 0,292) e ao trimetoprim-sulfametoxazol (TMP-SMX) (15,2% vs 14,1%, p = 0,659). As resistências à nitrofurantoína (9,0% vs 0,3%, p < 0.001) e à fosfomicina (1,7% vs 0,3%, p < 0,036) diminuíram significativamente entre o grupo 1 e o grupo 2.Conclusão: A E.coli mantém-se como o principal agente de infeções do trato urinário em pediatria. A resistência a A-C na nossa amostra é elevada (33,1%). A alteração de antibioterapia empírica de primeira-linha de A-C para cefuroxima resultou numa tendência de diminuição da resistência à A-C, sem aumento da resistência a cefuroxima.Ordem dos Médicos2025-02-03info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630Acta Médica Portuguesa; Vol. 38 No. 2 (2025): February; 79-87Acta Médica Portuguesa; Vol. 38 N.º 2 (2025): Fevereiro; 79-871646-07580870-399Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630/15597Direitos de Autor (c) 2025 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessSousa, PatríciaDelgado, LucindaCorreia-de-Oliveira, SusanaPereira, CecíliaDias, ÂngelaTavares, Ana Cláudia2025-02-09T03:00:52Zoai:ojs.www.actamedicaportuguesa.com:article/21630Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:46:42.311988Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
Infeções do Trato Urinário em Pediatria: Evolução da Etiologia e Padrões de Resistências Locais ao Longo de Três Anos
title Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
spellingShingle Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
Sousa, Patrícia
Child
Drug Resistance, Bacterial
Urinary Tract Infections/drug therapy
Urinary Tract Infections/etiology
Urinary Tract Infections/microbiology
Criança
Infeções do Trato Urinário/etiologia
Infeções do Trato Urinário/microbiologia
Infeções do Trato Urinário/tratamento farmacológico
Resistência Bacteriana a Medicamentos
title_short Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
title_full Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
title_fullStr Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
title_full_unstemmed Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
title_sort Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
author Sousa, Patrícia
author_facet Sousa, Patrícia
Delgado, Lucinda
Correia-de-Oliveira, Susana
Pereira, Cecília
Dias, Ângela
Tavares, Ana Cláudia
author_role author
author2 Delgado, Lucinda
Correia-de-Oliveira, Susana
Pereira, Cecília
Dias, Ângela
Tavares, Ana Cláudia
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Sousa, Patrícia
Delgado, Lucinda
Correia-de-Oliveira, Susana
Pereira, Cecília
Dias, Ângela
Tavares, Ana Cláudia
dc.subject.por.fl_str_mv Child
Drug Resistance, Bacterial
Urinary Tract Infections/drug therapy
Urinary Tract Infections/etiology
Urinary Tract Infections/microbiology
Criança
Infeções do Trato Urinário/etiologia
Infeções do Trato Urinário/microbiologia
Infeções do Trato Urinário/tratamento farmacológico
Resistência Bacteriana a Medicamentos
topic Child
Drug Resistance, Bacterial
Urinary Tract Infections/drug therapy
Urinary Tract Infections/etiology
Urinary Tract Infections/microbiology
Criança
Infeções do Trato Urinário/etiologia
Infeções do Trato Urinário/microbiologia
Infeções do Trato Urinário/tratamento farmacológico
Resistência Bacteriana a Medicamentos
description Introduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower.
publishDate 2025
dc.date.none.fl_str_mv 2025-02-03
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630/15597
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2025 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2025 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 38 No. 2 (2025): February; 79-87
Acta Médica Portuguesa; Vol. 38 N.º 2 (2025): Fevereiro; 79-87
1646-0758
0870-399X
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598319747661824